Loading...
Ovation Science (OVATF, $0.03) was a top loser over the last three months, falling -4 to $0.03 per share. A.I.dvisor analyzed 226 stocks in the Pharmaceuticals: Generic Industry for the 3-month period ending September 25, 2025, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend.
Industry PharmaceuticalsGeneric